TY - JOUR T1 - What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies JF - Journal of Neurology, Neurosurgery & Psychiatry JO - J Neurol Neurosurg Psychiatry SP - 319 LP - 323 DO - 10.1136/jnnp-2014-310256 VL - 87 IS - 3 AU - Roberto Erro AU - Susanne A Schneider AU - Maria Stamelou AU - Niall P Quinn AU - Kailash P Bhatia Y1 - 2016/03/01 UR - http://jnnp.bmj.com/content/87/3/319.abstract N2 - The term SWEDD (scans without evidence for dopaminergic deficit) refers to the absence, rather than the presence, of an imaging abnormality in patients clinically presumed to have Parkinson's disease (PD). However, such a term has since been widely used in the medical literature, even as a diagnostic label. While many authors have suggested that different disorders of PD lookalikes may account for a proportion of SWEDD cases, others have claimed that some of them may have a benign subtype of PD. Thus, there has been ensuing controversy and confusion and the use of this term continues without clarity of what it represents. We have systematically reviewed all the studies involving patients with SWEDD with the aim of shedding light on what these patients actually have. It becomes clear from this systematic review that while most ‘SWEDD’ cases are due to a clinical misdiagnosis of PD, there exists a small proportion of patients with SWEDD who may have PD on the basis of a positive levodopa response, clinical progression, imaging and/or genetic evidence. The latter challenge the seemingly incontrovertible relationship between dopaminergic tracer binding and the diagnosis of nigrostriatal parkinsonism, particularly PD. Patients with SWEDD are unlikely to reflect a single clinical entity and we suggest that the term SWEDD should be abandoned. ER -